BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hippocampus
,
Autoimmunity
,
Lipitor
,
rs4950928
,
IL1A
,
Angiogenesis
,
Arthritis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PD1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Superior cervical ganglion
Whole brain
Pons
Appendix
Cerebellum peduncles
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pulmonary hypertension
Abscess
Sepsis due to Serratia
Interstitial lung disease
Pneumonia
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
morpholineoethylamino-3-benzocyclohepta(5,6-c)pyridazine
Talampicillin
apramycin
Indoprofen
benzonatate
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
mir-7
FIGLA
COG7
CD101
PCDH7
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Spata2 Knockdown Exacerbates Brain Inflammation via NF-κB/P38MAPK Signaling and NLRP3 Inflammasome A…
PLK4 deubiquitination by Spata2-CYLD suppresses NEK7-mediated NLRP3 inflammasome activation at the c…
SPATA2 regulates the activation of RIPK1 by modulating linear ubiquitination.
SPATA2 restricts OTULIN-dependent LUBAC activity independently of CYLD.
LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Efficacy and Safety Evaluation of PD1-BCMA-CART
Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease (IT-P…
Impact of PD1-lymphocytes in Bronchoalveolar Lavage of Patients With Lung Cancer
PD1 and PARP for Maintenance Therapy in NSLLC
Biomarker Analysis of HIPEC Combined With PD1/PDL1 Inhibitor for Gastric Cancer With Peritoneal Meta…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ